Impact of an Electronic Health Record Maintenance Alert on PSA Screening Rates in a 10-Hospital Integrated Health System

Launched by WASHINGTON UNIVERSITY SCHOOL OF MEDICINE · Jul 31, 2025

Keywords

ClinConnect Summary

This clinical trial is studying whether an electronic alert system in doctors’ offices can help improve prostate cancer screening using the PSA test. The goal is to make sure men get the right screening at the right time, based on their risk, so prostate cancer can be found early without causing unnecessary worry or treatment. The system will remind healthcare providers when to talk with patients about screening, using clear guidelines to help make those decisions.

Men who get their care within the BJC Health System and have seen their primary care doctor at least once during the year may be eligible. Participants need to be male, have no history of prostate cancer, and fall into one of two groups: either they are at higher risk (such as African American men aged 40 to 75, or men with a family history of certain cancers) or they are average risk (men aged 50 to 75). If they join, participants can expect their doctors to use this alert system to guide conversations and decisions about PSA screening, aiming to catch cancer early while avoiding unnecessary tests. This study is not yet enrolling patients but will help improve how prostate cancer screening is done in the future.

Gender

MALE

Eligibility criteria

• Eligibility Criteria:
• • Receive care within the BJC Health System
• • Have had at least one primary care physician appointment in the calendar year of PSA screening (primary care)
• • Be male
• • Not have a history of prostate cancer
• * Meet one of the following risk criteria:
• • High Risk for Prostate Cancer
• • African American, between the ages of 40 and 75 (inclusive), or
• • Family history of prostate, breast, ovarian, and/or pancreatic cancer, or
• • Known familial germline mutation OR
• • Average Risk for Prostate Cancer
• • Between the ages of 50 and 75 (inclusive)